“↘공효일엔↗삼각지오피〔 YEOTOP1.COM 〕 삼각지오피ⅱ삼각지휴게텔く삼각지키스방✆삼각지출장ⅳ삼각지OP☲삼각지립카페”的搜索结果，显示 401-410 项，共有 9568 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... 2 years after CAR-T. Survey questionnaires that have been previously validated in cancer populations will be used to assess: overall quality of life ...

2. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

3. 神经科- 临床试验- 妙佑医疗国际

   The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

4. 神经科- 临床试验- 妙佑医疗国际

   The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

5. 神经科- 临床试验- 妙佑医疗国际

   The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

6. 神经科- 临床试验- 妙佑医疗国际

   The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

7. 神经科- 临床试验- 妙佑医疗国际

   The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

8. 神经科- 临床试验- 妙佑医疗国际

   117 研究神经科（仅限仍在招募的研究）. 按院区、状态和其他条件筛选该研究列表。 A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients ...

9. 神经科- 临床试验- 妙佑医疗国际

   The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

10. 神经科- 临床试验- 妙佑医疗国际

    117 研究神经科（仅限仍在招募的研究）. 按院区、状态和其他条件筛选该研究列表。 A Study to Evaluate Sex Differences in Multiple Sclerosis Spectrum of Demyelinating ...